BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Petrelli A, Rizzolio S, Pietrantonio F, Bellomo SE, et al. Cancer Res 2023 May 2:OF1-OF12. doi: 10.1158/0008-5472.CAN-22-2620.

Read + Share

Amedeo Smart

Independent Medical Education

Petrelli A, Rizzolio S, Pietrantonio F, Bellomo SE, et al. BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Cancer Res 2023 May 2:OF1-OF12. doi: 10.1158/0008-5472.CAN-22-2620.
PMID: 37129948